📰 Michael Polyviou News
Page 6 - Michael Polyviou News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Polyviou. Real-time updates on events, politics, business and more.
February 5, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Microbot Medical Granted Patent Allowance in Japan; Global Jurisdictions Recognizing Novel ’One ... Microbot MedicalFebruary 4, 2021 GMT HINGHAM, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) has received official notification from the Japan Patent Office (JPO) that it intends to grant the Company a patent for its ‘One & Done’ guidewire technology for use with end...
January 27, 2021
Microbot Medical Announces Successful Outcome of its Discussions with FDA Regarding Regulation of Self-Cleaning Shunt Microbot Medical Announces Successful Outcome of its Discussions with FDA Regarding Regulation of Self-Cleaning Shunt HINGHAM, Mass., Jan. 27, 2021 — Microbot Medical Inc. (Nasdaq: MBOT) announced the completion of successful discussions with the U.S. Food and Drug Administration (FDA) for its Self-Cleaning Shunt (SCS). After review of the Company’s existing pre-clinical da...
January 21, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Microbot Medical Enhances Scientific Advisory Board with World Renowned Interventional Radiologists Microbot MedicalJanuary 21, 2021 GMT HINGHAM, Mass., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) continues to enhance its thought leadership capabilities with the addition of several new Scientific Advisory Board (SAB) members: Stephen B. Solomon, MD, a board-certified radiolo...
January 16, 2021
Microbot Medical Demonstrates Significant Progress in 2020; Outlines Anticipated Milestones for 2021 Microbot Medical Demonstrates Significant Progress in 2020; Outlines Anticipated Milestones for 2021 HINGHAM, Mass., Jan. 11, 2021 — Microbot Medical Inc. (Nasdaq CM: MBOT) has concluded 2020 with the achievement of several operating and developmental milestones. The Company believes it is well positioned to leverage and capitalize upon this momentum through 2021, with plans to execute additio...